Gainers
- Xenetic Biosciences XBIO shares rose 20.37% to $3.9 during Thursday's pre-market session. The company's market cap stands at $37.8 million.
- Shattuck Labs STTK stock increased by 14.71% to $23.0. The company's market cap stands at $963.8 million. As per the press release, Q2 earnings came out yesterday.
- Xeris Pharmaceuticals XERS stock moved upwards by 13.61% to $2.67. The market value of their outstanding shares is at $177.5 million.
- CytoSorbents CTSO shares moved upwards by 13.33% to $8.84. The company's market cap stands at $383.3 million.
- Hims & Hers Health HIMS stock rose 11.22% to $8.42. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q2 earnings came out yesterday.
- Cano Health CANO stock increased by 9.75% to $11.7. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q2 earnings report came out today.
Losers
- VYNE Therapeutics VYNE shares decreased by 18.34% to $2.36 during Thursday's pre-market session. The company's market cap stands at $121.2 million. As per the news, the Q2 earnings report came out today.
- CohBar CWBR stock fell 10.5% to $1.45. The market value of their outstanding shares is at $89.5 million. As per the news, the Q2 earnings report came out 2 days ago.
- Trevena TRVN shares fell 8.58% to $1.28. The market value of their outstanding shares is at $210.5 million. The company's, Q2 earnings came out today.
- Aprea Therapeutics APRE shares declined by 8.05% to $3.77. The company's market cap stands at $79.8 million.
- Dyadic International DYAI stock declined by 7.77% to $4.87. The company's market cap stands at $134.1 million. As per the press release, Q2 earnings came out today.
- Schrodinger SDGR shares decreased by 6.53% to $58.75. The company's market cap stands at $4.1 billion. The company's, Q2 earnings came out today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in